{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:54Z","timestamp":1761560934551},"reference-count":109,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"vor","delay-in-days":2987,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p>In the United States, carvedilol and metoprolol (tartrate or succinate) are the most commonly employed beta\u2010adrenoreceptor antagonists for the treatment of heart failure. However, use of these agents in patients with heart failure remains extremely low despite overwhelming evidence of their beneficial short\u2010 and long\u2010term effects. Because the myocardial pathophysiology associated with heart failure involves not only \u03b2\u20101 adrenoreceptors but also \u03b2\u20102 and \u03b1\u20101 adrenoreceptors, this indicates a more complex disease process that may require pan\u2010receptor antagonism to provide optimal clinical benefit. Relative to metoprolol (tartrate or succinate), carvedilol represents an extremely complex molecular entity that not only possesses the ability to antagonize all of the principle adrenoreceptors involved in heart failure but also reduces oxidative stress and provides an antiarrhythmic benefit independent of beta\u2010adrenoreceptor antagonism. Taken together, an interesting pharmacologic premise for the superiority of carvedilol relative to metoprolol (tartrate) may exist, but the lack of clinical trials comparing an optimal dose of either extended\u2010release metoprolol (ie, succinate) or immediate\u2010release metoprolol (ie, tartrate) to carvedilol limits the clinical application of the pharmacologic differences between the agents.<\/jats:p>","DOI":"10.1177\/0091270004269841","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T18:13:07Z","timestamp":1103134387000},"page":"6-24","source":"Crossref","is-referenced-by-count":14,"title":["Critical Differences Among Beta\u2010Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET"],"prefix":"10.1002","volume":"45","author":[{"given":"Brian F.","family":"McBride","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results","volume":"247","author":"Beta Blocker Heart Attack Research Group","year":"1982","journal-title":"JAMA"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91101-6"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.73.3.503"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/9.suppl_L.8"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01683-7"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02670-0"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.6.561"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1997.tb02936.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1997.tb01506.x"},{"key":"e_1_2_7_11_2","article-title":"Examination of drug therapy patterns and relationship to heart failure hospitalization in Medicaid patients","author":"Howard PA","journal-title":"Am J Manage Care"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.07.022"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00012-S"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00420-1"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90036-X"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01158-X"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13801-9"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.2.212"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2793"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342101"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2800"},{"issue":"349","key":"e_1_2_7_22_2","first-page":"375","article-title":"Australia\u2010New Zealand Heart Failure Research Collaborative Group. Randomised, placebo controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease","volume":"34","year":"1997","journal-title":"Lancet"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442201"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.6.712"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00838-2"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.72.3.536"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90114-7"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70083-9"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01006-8"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.10.1295"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92930-R"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01970-8"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2817"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00134-5"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.20.2645"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13800-7"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(04)90876-5"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04387.x"},{"key":"e_1_2_7_39_2","first-page":"3","volume-title":"Heart Failure: Pathogenesis and Treatment","author":"Katz AM.","year":"2002"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207223070401"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.74.6.1290"},{"key":"e_1_2_7_42_2","first-page":"59","volume-title":"Heart Failure: Pathogenesis and Treatment","author":"Abdellatif M","year":"2002"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00846-1"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.1.169"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115659"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00332-0"},{"key":"e_1_2_7_47_2","doi-asserted-by":"crossref","first-page":"17953","DOI":"10.1074\/jbc.270.30.17953","article-title":"Phosphorylation and desensitization of the human \u03b2\u20101 adrenergic receptor","volume":"270","author":"Freedman NJ","year":"1995","journal-title":"J Biol Chem"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114429"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.59.3.297"},{"key":"e_1_2_7_50_2","first-page":"295","article-title":"\u03b21 and \u03b22 adrenergic receptor mediated adenylate cyclase stimulation in nonfailing and filing human ventricular myocardium","volume":"35","author":"Bristow MR","year":"1989","journal-title":"Mol Pharmacol."},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.5.558"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.6.1356"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01200-6"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2001.tb00097.x"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2001.tb00125.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02850-4"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00104-1"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00204-4"},{"key":"e_1_2_7_59_2","doi-asserted-by":"crossref","first-page":"26743","DOI":"10.1016\/S0021-9258(19)61438-9","article-title":"Functional coupling of human beta\u20103 adrenoreceptors to the KvLQT1\/MinK potassium channel","volume":"275","author":"Kathhofer S","year":"2000","journal-title":"J Biol Chem"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00034-4"},{"key":"e_1_2_7_61_2","article-title":"The electrocardiographic impact of catecholamines among patients at high risk of ventricular arrhythmogenesis","author":"McBride BF","journal-title":"J Electrocardiol"},{"key":"e_1_2_7_62_2","first-page":"18.1","volume-title":"Applied Therapeutics: The Clinical Use of Drugs","author":"White CM","year":"2001"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.1.168"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351603"},{"key":"e_1_2_7_65_2","first-page":"I","article-title":"Higher incidence of cardiocyte apoptosis in failing explanted hearts of patients with ischemic versus idiopathic dilated cardiomyopathy [abstract]","volume":"96","author":"Sharov VG","year":"1997","journal-title":"Circulation"},{"key":"e_1_2_7_66_2","first-page":"230A","article-title":"Norepinephrine directly induces apoptosis in neonatal rat myocytes","volume":"29","author":"Matsui T","year":"1997","journal-title":"J Am Coll Cardiol."},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.13.1329"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1996.0333"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.1.140"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119114"},{"key":"e_1_2_7_71_2","first-page":"135","article-title":"Relationships between carvedilol stereoisomer plasma concentrations and b\u2010receptor occupancies in subjects with chronic heart failure in the Multicenter Oral Carvedilol Heart Failure Assessment (MOCHA) trial [abstract]","volume":"17","author":"Bristow MR","year":"1996","journal-title":"Eur Heart J."},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199219001-00014"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.67.83"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.79.3.483"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(98)00099-6"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4301.098282"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(01)00220-3"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00658-1"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89316-2"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00900-1"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00616-4"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.17.1783"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00053-3"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200209000-00014"},{"key":"e_1_2_7_85_2","first-page":"910","article-title":"Carvedilol, a multiple action neurohormonal antagonist, inhibits mitogen activated protein kinase and cell cycle progression in vascular smooth muscle cells","volume":"283","author":"Sung CP","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.212"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00368-4"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00265-0"},{"key":"e_1_2_7_89_2","first-page":"933","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Roden DM.","year":"2001"},{"key":"e_1_2_7_90_2","first-page":"1023","article-title":"Ranolazine attenuates the prolongation of ventricular monophasic action potential and suppresses ventricular tachycardia caused by sea anemone toxin ATX\u2010II in guinea pig isolated myocytes [abstract]","volume":"26","author":"Wu L","year":"2003","journal-title":"PACE"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(04)90579-7"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(04)90599-2"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.216"},{"key":"e_1_2_7_94_2","article-title":"The electrocardiographic impact of catecholamines among patients at high risk of ventricular arrhythmogenesis receiving chronic carvedilol","author":"McBride BF","journal-title":"J Electrocardiol"},{"key":"e_1_2_7_95_2","first-page":"S22","article-title":"Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure","volume":"32","author":"Ruffolo RR","year":"1998","journal-title":"J Cardiovasc Pharmacol."},{"key":"e_1_2_7_96_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.11.1919"},{"key":"e_1_2_7_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200008000-00020"},{"key":"e_1_2_7_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00522-0"},{"key":"e_1_2_7_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00275-5"},{"key":"e_1_2_7_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00369-7"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.34"},{"key":"e_1_2_7_102_2","unstructured":"Metoprolol pharmacokinetics. AccessedApril 17 2004 athttp:\/\/micromedex.uchc.edu\/mdxcgi\/display.exe?CTL=E:mdxmdxcgimegat.sys&SET=1C424EBD0DF6F00&SYS=1&T=356&D=275."},{"key":"e_1_2_7_103_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426050-00002"},{"key":"e_1_2_7_104_2","volume-title":"Coreg (Carvedilol) [package insert]","year":"2002"},{"key":"e_1_2_7_105_2","volume-title":"Lopressor (Metoprolol Tartrate) [package insert]","year":"2004"},{"key":"e_1_2_7_106_2","volume-title":"Toprol XL (Metoprolol Succinate) [package insert]","year":"2002"},{"key":"e_1_2_7_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.6"},{"key":"e_1_2_7_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1990.tb03491.x"},{"key":"e_1_2_7_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00578406"},{"key":"e_1_2_7_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01471-1"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1177%2F0091270004269841","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/0091270004269841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:42:37Z","timestamp":1697157757000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1177\/0091270004269841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1177\/0091270004269841"],"URL":"https:\/\/doi.org\/10.1177\/0091270004269841","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}